Free Trial

Ruffer LLP Sells 148,590 Shares of Nutrien Ltd. (NYSE:NTR)

Nutrien logo with Basic Materials background
Remove Ads

Ruffer LLP lessened its stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 13.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 982,728 shares of the company's stock after selling 148,590 shares during the period. Nutrien comprises about 1.6% of Ruffer LLP's holdings, making the stock its 19th biggest position. Ruffer LLP owned about 0.20% of Nutrien worth $43,977,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC boosted its position in Nutrien by 6.5% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company's stock worth $207,000 after purchasing an additional 263 shares during the period. US Bancorp DE boosted its position in Nutrien by 15.5% during the third quarter. US Bancorp DE now owns 23,574 shares of the company's stock worth $1,133,000 after purchasing an additional 3,157 shares during the period. Farther Finance Advisors LLC boosted its position in Nutrien by 217.0% during the third quarter. Farther Finance Advisors LLC now owns 3,500 shares of the company's stock worth $168,000 after purchasing an additional 2,396 shares during the period. Janney Montgomery Scott LLC boosted its position in Nutrien by 25.7% during the third quarter. Janney Montgomery Scott LLC now owns 97,635 shares of the company's stock worth $4,692,000 after purchasing an additional 19,984 shares during the period. Finally, Townsend & Associates Inc boosted its position in Nutrien by 97.5% during the third quarter. Townsend & Associates Inc now owns 562,846 shares of the company's stock worth $26,887,000 after purchasing an additional 277,875 shares during the period. Hedge funds and other institutional investors own 63.10% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

NTR has been the subject of a number of research reports. CIBC increased their target price on shares of Nutrien from $64.00 to $66.00 and gave the stock an "outperformer" rating in a research report on Tuesday, February 25th. TD Securities cut their target price on shares of Nutrien from $63.00 to $61.00 and set a "buy" rating for the company in a research report on Tuesday, November 12th. Mizuho raised their price objective on shares of Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a research report on Thursday, February 20th. UBS Group raised their price objective on shares of Nutrien from $53.00 to $54.00 and gave the company a "neutral" rating in a research report on Thursday, February 20th. Finally, Piper Sandler raised their price objective on shares of Nutrien from $58.00 to $63.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $60.13.

Check Out Our Latest Research Report on Nutrien

Nutrien Price Performance

NTR stock traded down $0.44 during midday trading on Wednesday, reaching $50.75. The company had a trading volume of 1,452,489 shares, compared to its average volume of 1,987,944. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien Ltd. has a 1 year low of $43.70 and a 1 year high of $60.87. The company has a market capitalization of $24.83 billion, a P/E ratio of 37.04, a P/E/G ratio of 1.19 and a beta of 0.81. The firm has a 50-day moving average price of $51.08 and a 200-day moving average price of $48.65.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to analysts' expectations of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, research analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Monday, March 31st will be issued a $0.545 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a dividend yield of 4.30%. Nutrien's payout ratio is 159.12%.

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads